Viewing nowOkamaril 4mg Tablet (Glimepiride)
Glimepiride 4mg
Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.

MFDS item code 201604202 · Approved 2016.07.07 · Insurance code 629701110
Improvement of blood glucose control in type 2 diabetes mellitus
This medication helps control blood sugar levels in patients with type 2 diabetes. It is used in conjunction with dietary and exercise therapies to improve blood sugar management. It can be used alone, or sometimes in combination with other glucose-lowering medications or insulin for better control of blood sugar levels. For example, it can be used in conjunction with insulin when control with oral antidiabetic agents is difficult, and it may also be used alongside sulfonylureas or metformin. This medication is used in various ways to effectively improve blood sugar in patients.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional effect with doses above 4 mg, although some patients have achieved better metabolic control with increases to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic agent. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the instructions under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2 week intervals. The potency and duration of action of the previous medication should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur despite successful initial management during treatment with a sulfonylurea. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately once a week according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the dose of each medicine may be adjusted to achieve the desired blood glucose level. However, efforts should be made to identify the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia with concomitant use of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or those in a comatose state. Additionally, it should not be administered to patients with allergies to this medication or sulfonylureas, those with severe liver or kidney dysfunction, and pregnant or breastfeeding women. For patients with severe infections, pre- and post-surgery, or severe trauma, insulin therapy is recommended, and patients with gastrointestinal issues should be cautious of hypoglycemia risk. In the early stages of treatment, the risk of hypoglycemia is higher, so blood sugar levels should be closely monitored, especially in patients who are malnourished, have irregular meals, are elderly, have reduced liver or kidney function, or are taking other medications. Hypoglycemia symptoms can include headache, severe hunger, nausea, fatigue, confusion, drowsiness, and loss of consciousness, so immediate sugar intake is necessary if symptoms occur. Furthermore, this medication may cause various side effects such as liver dysfunction, blood abnormalities, allergic reactions, and gastrointestinal disturbances, so any unusual symptoms should be reported immediately to a doctor or pharmacist. When taking this medication, it is important to adhere to dietary and exercise regimens, as well as to take it regularly. In the event of hypoglycemia, consuming sugar or sugary drinks can alleviate symptoms, while artificial sweeteners are ineffective. When combined with other medications, blood sugar control may be affected, so it is essential to inform the doctor of any other medications being taken. Pregnant or breastfeeding women should not use this medication; switching to insulin therapy is safer if needed. In case of overdose, severe hypoglycemia may occur, requiring immediate emergency care, and treatment should follow a doctor's guidance. This medication has not been established for safety and efficacy in children, and elderly patients may require dosage adjustments due to reduced kidney function. Store this medication in a place out of reach of children, and keep it in its original container to maintain its quality.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbance, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, speech disturbance, aphasia, visual impairment, tremors, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, cerebral seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and moist skin, tachycardia, hypertension, palpitations, angina, venous arrhythmia, blurred vision, feelings of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, biliary secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is best to store the medication at room temperature, not too hot or cold, specifically between 1 and 30 degrees Celsius.
Light blue oblong tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 4mg
Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.